
Integer Holdings Corporation ITGR
$ 126.97
-0.01%
Integer Holdings Corporation Book Value | ITGR
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Integer Holdings Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.75 B | 1.62 B | 1.52 B | 1.42 B | 1.35 B | 1.27 B | 1.15 B | 1.06 B | 893 M | 851 M | 613 M | 542 M | - | 481 M | 467 M | 427 M | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.75 B | 427 M | 1.03 B |
Quarterly Book Value Integer Holdings Corporation
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.73 B | 1.72 B | 1.7 B | 1.75 B | 1.75 B | 1.7 B | 1.61 B | 1.62 B | 1.62 B | 1.55 B | 1.53 B | 1.52 B | 1.46 B | 1.45 B | 1.42 B | 1.42 B | 1.36 B | 1.36 B | 1.36 B | 1.35 B | 1.33 B | 1.31 B | 1.28 B | 1.27 B | 1.23 B | 1.18 B | 1.16 B | 1.15 B | 1.13 B | 1.11 B | 1.08 B | 1.06 B | 1.04 B | 918 M | 920 M | 893 M | 823 M | 783 M | 741 M | 725 M | 741 M | 723 M | 732 M | 851 M | 646 M | 642 M | 628 M | 613 M | 597 M | 583 M | 567 M | 541 M | 524 M | 503 M | 489 M | 481 M | 481 M | 484 M | 483 M | 467 M | 464 M | 464 M | 467 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.75 B | 464 M | 1.04 B |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
LENSAR
LNSR
|
-12.2 M | $ 4.48 | -3.45 % | $ 53.6 M | ||
|
Orthofix Medical
OFIX
|
450 M | $ 6.05 | -4.57 % | $ 240 M | ||
|
Pulmonx Corporation
LUNG
|
54.1 M | $ 2.56 | -6.57 % | $ 104 M | ||
|
InspireMD
NSPR
|
55.2 M | $ 0.54 | -12.97 % | $ 34.7 M | ||
|
InMode Ltd.
INMD
|
683 M | $ 12.41 | -2.32 % | $ 802 M | ||
|
OrthoPediatrics Corp.
KIDS
|
347 M | $ 31.7 | -2.49 % | $ 744 M | ||
|
Outset Medical
OM
|
127 M | $ 2.83 | -2.75 % | $ 43 M | ||
|
PAVmed
PAVM
|
22.3 M | $ 1.28 | 6.66 % | $ 858 K | ||
|
AVITA Medical
RCEL
|
-16.6 M | $ 15.66 | -2.1 % | $ 436 M | ||
|
Viemed Healthcare
VMD
|
144 M | $ 8.55 | -0.75 % | $ 333 M | ||
|
Vivos Therapeutics
VVOS
|
-1.55 M | $ 0.05 | -8.08 % | $ 514 K | ||
|
CHF Solutions, Inc.
CHFS
|
6.23 M | - | 1.15 % | $ 34.5 M | ||
|
Soliton, Inc.
SOLY
|
243 M | - | -1.42 % | $ 435 M | ||
|
Itamar Medical Ltd.
ITMR
|
229 M | - | 0.03 % | $ 1.58 B | ||
|
Zimmer Biomet Holdings
ZBH
|
12.7 B | $ 101.25 | -0.24 % | $ 20 B | ||
|
Misonix, Inc.
MSON
|
30.4 M | - | - | $ 462 M | ||
|
Intersect ENT, Inc.
XENT
|
550 M | - | - | $ 955 M | ||
|
Beyond Air
XAIR
|
6.21 M | $ 1.58 | -8.43 % | $ 13.1 B | ||
|
Varex Imaging Corporation
VREX
|
487 M | $ 18.1 | -0.22 % | $ 749 M | ||
|
Xtant Medical Holdings
XTNT
|
51 M | $ 0.2 | -7.4 % | $ 27.9 M | ||
|
AdaptHealth Corp.
AHCO
|
1.53 B | $ 7.2 | -0.76 % | $ 973 M | ||
|
CryoLife, Inc.
CRY
|
58.1 M | - | -4.14 % | $ 702 M | ||
|
Inspire Medical Systems
INSP
|
781 M | $ 54.97 | -2.54 % | $ 1.61 B | ||
|
Avanos Medical
AVNS
|
778 M | $ 24.99 | - | $ 1.16 B | ||
|
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
133 M | - | 37.08 % | $ 85.7 M | ||
|
Helius Medical Technologies
HSDT
|
301 M | $ 1.51 | -9.34 % | $ 33.3 M | ||
|
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
15.7 M | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
160 M | - | - | $ 140 M | ||
|
GBS
GBS
|
5.29 M | - | -0.57 % | $ 7.12 M | ||
|
NanoVibronix
NAOV
|
33.5 M | - | - | $ 1.08 M | ||
|
Ra Medical Systems
RMED
|
6.65 M | - | 10.0 % | $ 610 K | ||
|
ReWalk Robotics Ltd.
RWLK
|
8.41 M | - | 7.07 % | $ 66.1 M | ||
|
STRATA Skin Sciences
SSKN
|
2.91 M | - | - | $ 6.6 M | ||
|
EDAP TMS S.A.
EDAP
|
40.9 M | - | - | $ 162 M | ||
|
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | ||
|
Zynex
ZYXI
|
35.7 M | - | - | $ 21.1 M | ||
|
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | ||
|
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M | ||
|
CONMED Corporation
CNMD
|
1.03 B | $ 46.69 | 0.39 % | $ 1.45 B | ||
|
ShockWave Medical
SWAV
|
669 M | - | - | $ 12.3 B | ||
|
Nevro Corp.
NVRO
|
231 M | - | - | $ 217 M | ||
|
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | ||
|
Axonics Modulation Technologies
AXNX
|
638 M | - | - | $ 3.31 B | ||
|
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | ||
|
ThermoGenesis Holdings
THMO
|
-3.58 M | - | -25.84 % | $ 171 K | ||
|
Talis Biomedical Corporation
TLIS
|
69.1 M | - | 3.55 % | $ 7.96 M | ||
|
Abiomed
ABMD
|
1.5 B | - | - | $ 17.2 B | ||
|
Titan Medical
TMDI
|
35.3 M | - | -26.32 % | $ 19.6 M |